Biosimilar and Biologics Market to Reach USD 1,257.3 Million by 2036 as Demand for Cost-Effective Biologic Therapies Accelerates
The Biosimilar and Biologics Market is expected to witness robust expansion as healthcare systems worldwide increasingly adopt cost-effective biologic therapies to improve patient access and reduce treatment costs. According to Future Market Insights (FMI), the market is projected to grow from USD 604.4 million in 2026 to USD 1,257.3 million by 2036, registering a 7.6% CAGR during the forecast...
0 Comments 0 Shares 256 Views 0 Reviews